• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

The impact of omalizumab on paid and unpaid work productivity among severe Japanese cedar pollinosis (JCP) patients
CONCLUSIONS: Omalizumab could provide substantial benefits in terms of paid and unpaid work activities in patients with severe and most severe JCP. Our results also highlight the importance of considering unpaid work in estimating productivity costs due to poor health.PMID:35072591 | DOI:10.1080/13696998.2022.2033051
Source: Journal of Medical Economics - January 24, 2022 Category: Health Management Authors: M M üller A Igarashi K Hashiguchi M Kappel F Paolini H Yoshisue M Funakubo H Sharma M Okano Source Type: research

Pharmacoeconomics of allergy immunotherapy versus pharmacotherapy
Expert Rev Clin Immunol. 2021 Feb 28:1-13. doi: 10.1080/1744666X.2021.1886079. Online ahead of print.ABSTRACTIntroduction: The purpose of this review is to evaluate the cost-effectiveness of allergy immunotherapy (AIT) in the treatment of allergic rhinitis, asthma, and other allergic conditions.Area covered: An extensive search of the PubMed and Medline database (January 1996 up to June of 2020) was conducted using the search terms allergy immunotherapy, pharmacoeconomics, cost-effectiveness, allergic rhinitis, and asthma. Studies were included if they included information on the economics of AIT in comparison to pharmacot...
Source: Expert Review of Clinical Immunology - March 1, 2021 Category: Allergy & Immunology Authors: Linda Cox Source Type: research

A quality of life mapping function developed from a grass pollen sublingual immunotherapy trial to a tree pollen sublingual immunotherapy trial.
Conclusions: Application of the mapping function enabled the calculation of QALDs associated with the treatment, with the caveat that data were extrapolated from grass seasonal allergy to tree seasonal allergy. The results showed a significant QALD benefit of the treatment over placebo in treatment of tree pollen-induced rhinoconjunctivitis. PMID: 31352853 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - July 31, 2019 Category: Health Management Tags: J Med Econ Source Type: research

Impact of increasing treatment rates on cost-effectiveness of subcutaneous immunotherapy (SCIT) in respiratory allergy: a decision analytic modelling approach
ConclusionsMeasures to increase SCIT initiation rates should be implemented and also address improving adherence.
Source: The European Journal of Health Economics - March 24, 2018 Category: Health Management Source Type: research

Cost-effectiveness of grass pollen subcutaneous immunotherapy (SCIT) compared to sublingual immunotherapy (SLIT) and symptomatic treatment in Austria, Spain and Switzerland.
CONCLUSION: In patients with allergic rhinitis, SIT offers cost-effective treatment options compared to symptomatic treatment. When comparing SCIT (Allergovit) and SLIT (Oralair), SCIT was dominant in terms of QALYs as well as costs, in particular due to a slightly higher patient compliance and lower drug costs. PMID: 29271271 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - December 23, 2017 Category: Health Management Tags: J Med Econ Source Type: research

Multiple Threats to Child Health from Fossil Fuel Combustion: Impacts of Air Pollution and Climate Change
Conclusion: Going beyond the powerful scientific and economic arguments for urgent action to reduce the burning of fossil fuels is the strong moral imperative to protect our most vulnerable populations. Citation: Perera FP. 2017. Multiple threats to child health from fossil fuel combustion: impacts of air pollution and climate change. Environ Health Perspect 125:141–148; http://dx.doi.org/10.1289/EHP299 Address correspondence to F.P. Perera, Department of Environmental Health Sciences, Columbia Center for Children’s Environmental Health, Columbia University Mailman School of Public Health, 722 West 168th St. 12th flo...
Source: EHP Research - February 1, 2017 Category: Environmental Health Authors: Web Admin Tags: Commentaries Children's Health February 2017 Source Type: research

Patient preferences in allergy immunotherapy (AIT) in Germany – a discrete-choice-experiment
Allergic Rhinitis (AR) is a common disorder in Europe with Allergic Asthma (AA) as a frequent comorbidity. Allergy immunotherapy (AIT) is the only causal therapy of AR and AA, and can be administered as subcut...
Source: Health Economics Review - August 2, 2016 Category: Health Management Authors: Kathrin Damm, Janina Volk, Andreas Horn, Jean-Pierre Allam, Ninette Troensegaard-Petersen, Niels Serup-Hansen, Thomas Winkler, Ivonne Thiessen, Kathrin Borchert, Eike G. W üstenberg and Thomas Mittendorf Source Type: research

Cost-minimisation analysis of sublingual immunotherapy versus subcutaneous immunotherapy for house dust mite respiratory allergic disease in Denmark.
CONCLUSION: With regards to the cost of treating Danish patients with HDM RAD, it is clearly cost-saving to treat patients with SQ® SLIT-tablet compared to SQ® SCIT. PMID: 26909663 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - February 26, 2016 Category: Health Management Tags: J Med Econ Source Type: research

Allergy immunotherapy: what is the evidence for cost saving?
Purpose of reviewGiven the widespread prevalence of allergic disease, its substantially associated clinical and economic burden, the unique disease-modifying benefits of allergy immunotherapy (AIT), and increased availability of sublingual immunotherapy (SLIT), a critical update of the evidence for AIT-related cost savings [for both subcutaneous immunotherapy (SCIT) and SLIT] is particularly relevant and timely. The present article reviews the evidence for SCIT-related and SLIT-related cost savings derived from a systematic review of the published literature. Recent findingsExamined were 24 publications pertaining to the h...
Source: Current Opinion in Allergy and Clinical Immunology - May 23, 2013 Category: Allergy & Immunology Tags: PHARMACOTHERAPY AND EVIDENCE BASED MEDICINE: Edited by David A. Khan and Enrico Compalati Source Type: research